CLINICAL_TRIALS
ClinicalTrials.gov record update
A Prospective, Single-arm, Single-center, Exploratory Phase II Study to Evaluate the Efficacy and Safety of Anlotinib Combined With Dose-reduced Olaparib in Patients With Platinum-Sensitive Recurrent Ovarian Cancer
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT04566952
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-28T10:37:57.469550+00:00
- Published At
- 2020-10-30T00:00:00+00:00
- Record Updated At
- 2020-10-30
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Ovarian Cancer", "Ovarian and Fallopian Tube Cysts and Neoplasms", "Neoplasms by Site", "Neoplasms", "Genital Neoplasms, Female", "Urogenital Neoplasms", "Neoplasms, Glandular and Epithelial", "Neoplasms by Histologic Type", "Carcinoma, Ovarian Epithelial", "Ovarian Diseases", "Adnexal Diseases", "Genital Diseases, Female", "Carcinoma", "Anlotinib", "PARP Inhibitors", "BRCA1 Mutation", "Angiogenesis", "Antineoplastic Agents", "BRCA2 Mutation"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2020-10-30"- protocolSection.identificationModule.nctId
"NCT04566952"- protocolSection.identificationModule.officialTitle
"A Prospective, Single-arm, Single-center, Exploratory Phase II Study to Evaluate the Efficacy and Safety of Anlotinib Combined With Dose-reduced Olaparib in Patients With Platinum-Sensitive Recurrent Ovarian Cancer"- protocolSection.statusModule.overallStatus
"UNKNOWN"- protocolSection.designModule.phases
["PHASE2"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.